RNU7-196P

Across TCGA pan-cancer cohorts, RNU7-196P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU7-196P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU7-196P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-196P expression acts as an unfavorable survival marker, although some lineages such as LUAD and OV show a favorable association.

ACC, THYM, and ESCA are the cancer types where RNU7-196P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	III,IV	0.353	0.765	.001	72	view →
THYM	OS	Tertile	All	0.186	0.880	<.001	45	view →
ESCA	OS	Quartile	II,III,IV	0.315	0.535	.013	30	view →
UCEC	DFS	Tertile	All	0.745	0.898	.010	30	view →
READ	OS	Tertile	All	0.281	0.823	<.001	27	view →
LUAD	DFS	Tertile	All	0.892	0.655	.030	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
OV	OS	Tertile	All	0.930	0.832	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU7-196P–ACC (OS)

Open the ACC breakdown →